Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Rutgers

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|April 13, 2018
Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis?Kornelis S M van der Geest, Maria Sandovici, Yannick van Sleen, et al.
Journal of the American Geriatrics Society|March 22, 2024
The link between the early surgery-induced inflammatory response and postoperative cognitive dysfunction in older patientsBaukje Brattinga, Matthijs Plas, Jacoba M Spikman, et al.
Frontiers in Immunology|May 3, 2024
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination programLeanne P M van Leeuwen, Marloes Grobben, Corine H GeurtsvanKessel, et al.
Annals of the Rheumatic Diseases|May 28, 2026
Single-cell multiomics reveals activation of the STAT3-PIM1 axis in T-cell subsets in proteinase 3-ANCA-positive granulomatosis with polyangiitisNanthicha Inrueangsri, Carlo G Bonasia, Kevin P Mennega, et al.
Journal of Clinical Immunology|May 25, 2023
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of ImmunityLeanne P M van Leeuwen, Marloes Grobben, Corine H GeurtsvanKessel, et al.
Rheumatology (Oxford, England)|February 9, 2024
Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirementOlof C B Vermeulen, Elisabeth Brouwer, Riemer H J A Slart, et al.
Scientific Reports|April 28, 2025
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapyAnika M Valk, Jana Koers, Ninotska I L Derksen, et al.
Nature Reviews. Rheumatology|October 16, 2025
Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitisMarta Casal Moura, Peter A Merkel, David Jayne, et al.
Rheumatology Advances in Practice|July 5, 2022
Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patientsEbru Dirikgil, Sander W Tas, Cornelis A Verburgh, et al.
The Journal of Rheumatology|June 7, 2007
The future of damage assessment in vasculitisPhilip Seo, Raashid A Luqmani, Oliver Flossmann, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Arthritis & Rheumatology (Hoboken, N.J.)|April 13, 2018
Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis?Kornelis S M van der Geest, Maria Sandovici, Yannick van Sleen, et al.
Journal of the American Geriatrics Society|March 22, 2024
The link between the early surgery-induced inflammatory response and postoperative cognitive dysfunction in older patientsBaukje Brattinga, Matthijs Plas, Jacoba M Spikman, et al.
Frontiers in Immunology|May 3, 2024
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination programLeanne P M van Leeuwen, Marloes Grobben, Corine H GeurtsvanKessel, et al.
Annals of the Rheumatic Diseases|May 28, 2026
Single-cell multiomics reveals activation of the STAT3-PIM1 axis in T-cell subsets in proteinase 3-ANCA-positive granulomatosis with polyangiitisNanthicha Inrueangsri, Carlo G Bonasia, Kevin P Mennega, et al.
Journal of Clinical Immunology|May 25, 2023
Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of ImmunityLeanne P M van Leeuwen, Marloes Grobben, Corine H GeurtsvanKessel, et al.
Rheumatology (Oxford, England)|February 9, 2024
Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirementOlof C B Vermeulen, Elisabeth Brouwer, Riemer H J A Slart, et al.
Scientific Reports|April 28, 2025
Elevated Fab glycosylation of autoantibodies maintained during B cell depletion therapyAnika M Valk, Jana Koers, Ninotska I L Derksen, et al.
Nature Reviews. Rheumatology|October 16, 2025
Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitisMarta Casal Moura, Peter A Merkel, David Jayne, et al.
Rheumatology Advances in Practice|July 5, 2022
Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patientsEbru Dirikgil, Sander W Tas, Cornelis A Verburgh, et al.
The Journal of Rheumatology|June 7, 2007
The future of damage assessment in vasculitisPhilip Seo, Raashid A Luqmani, Oliver Flossmann, et al.
Pageof 10